Source - SMW
Cambridge Cognition Holdings has signed  two major contracts using the company's CANTAB Connect technology.   The contracts totalling US$3.67million are with US biopharmaceutical companies for late stage clinical trials and will contribute US$1.07 million to reported revenue in the second half of 2016. 

The award of the contracts was expected and so the outlook for the current year remains unchanged.